AANS Neurosurgeon | Volume 27, Number 1, 2018

Advertisement

Newly Discovered Biomarkers May Lead to Promising Diagnostic Tool for Alzheimer’s

Approach could offer stage-specific prognosis, open door to better treatment

 

Diagnosing Alzheimer’s disease and determining a patient’s prognosis is an inexact business, and that stands in the way of better personalized care and advances in treatment. 

First, the team of researchers discovered new physical biomarkers that could help pinpoint a diagnosis – changes to proteins found in the spinal fluid and blood of patients. In particular, as Alzheimer’s severity increased, the proteins were longer, more rigid and more clustered, said lead researcher Mingjun Zhang, a professor of biomedical engineering at Ohio State.

Click here to read more.

Calendar/Courses

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Surgical Approaches to Skull Base
April 26-28, 2018; St. Louis, MO

2018 AANS Annual Scientific Meeting
April 28-May 2, 2018; New Orleans

Comments are closed.